申请人:Gilead Sciences, Inc.
公开号:EP3954679A2
公开(公告)日:2022-02-16
Compounds of formula I:
or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
式 I 的化合物:
或其盐类。还公开了包含式 I 化合物的药物组合物、制备式 I 化合物的工艺、用于制备式 I 化合物的中间体以及治疗逆转录病毒科病毒感染(包括由 HIV 病毒引起的感染)的治疗方法。